Variant report
Variant | nsv947327 |
---|---|
Chromosome Location | chr1:154067393-154086846 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:191)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 1)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr1:154076946-154077375 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | BHLHE40 | chr1:154076990-154077104 | K562 | blood: | n/a | n/a |
3 | CBX3 | chr1:154070957-154071201 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr1:154071082-154071123 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CTCF | chr1:154077000-154077150 | MCF-7 | breast: | n/a | n/a |
6 | CTCF | chr1:154077302-154077425 | GM19240 | blood: | n/a | n/a |
7 | CTCF | chr1:154076980-154077130 | GM12870 | blood: | n/a | n/a |
8 | CTCF | chr1:154077000-154077150 | GM12875 | blood: | n/a | n/a |
9 | CTCF | chr1:154077078-154077136 | Fibrobl | skin: | n/a | n/a |
10 | CTCF | chr1:154077017-154077181 | A549 | lung: | n/a | n/a |
11 | CTCF | chr1:154077300-154077450 | GM12864 | blood: | n/a | n/a |
12 | CTCF | chr1:154077057-154077117 | GM10266 | blood: | n/a | n/a |
13 | CTCF | chr1:154077020-154077170 | HCT-116 | colon: | n/a | n/a |
14 | CTCF | chr1:154077040-154077190 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr1:154077328-154077424 | GM10248 | blood: | n/a | n/a |
16 | CTCF | chr1:154077013-154077167 | GM19240 | blood: | n/a | n/a |
17 | CTCF | chr1:154077011-154077182 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr1:154077040-154077190 | GM12871 | blood: | n/a | n/a |
19 | CTCF | chr1:154076908-154077480 | K562 | blood: | n/a | n/a |
20 | CTCF | chr1:154077000-154077150 | HMEC | breast: | n/a | n/a |
21 | CTCF | chr1:154076740-154076890 | GM06990 | blood: | n/a | n/a |
22 | CTCF | chr1:154076860-154077622 | MCF-7 | breast: | n/a | n/a |
23 | CTCF | chr1:154077280-154077430 | GM12871 | blood: | n/a | n/a |
24 | CTCF | chr1:154077332-154077429 | GM10266 | blood: | n/a | n/a |
25 | CTCF | chr1:154077020-154077170 | HepG2 | liver: | n/a | n/a |
26 | CTCF | chr1:154077000-154077150 | GM12867 | blood: | n/a | n/a |
27 | CTCF | chr1:154077020-154077170 | NHEK | skin: | n/a | n/a |
28 | CTCF | chr1:154077010-154077183 | GM12892 | blood: | n/a | n/a |
29 | CTCF | chr1:154076885-154077609 | HCT-116 | colon: | n/a | n/a |
30 | CTCF | chr1:154077240-154077390 | HEEpiC | esophagus: | n/a | n/a |
31 | CTCF | chr1:154077236-154077470 | MCF-7 | breast: | n/a | n/a |
32 | CTCF | chr1:154077280-154077430 | RPTEC | kidney: | n/a | n/a |
33 | CTCF | chr1:154076965-154077163 | GM12891 | blood: | n/a | n/a |
34 | CTCF | chr1:154077280-154077430 | HEEpiC | esophagus: | n/a | n/a |
35 | CTCF | chr1:154076989-154077375 | K562 | blood: | n/a | n/a |
36 | CTCF | chr1:154076980-154077130 | GM12872 | blood: | n/a | n/a |
37 | CTCF | chr1:154077001-154077205 | MCF-7 | breast: | n/a | n/a |
38 | CTCF | chr1:154076987-154077484 | MCF-7 | breast: | n/a | n/a |
39 | CTCF | chr1:154077260-154077410 | HMEC | breast: | n/a | n/a |
40 | CTCF | chr1:154077040-154077190 | GM06990 | blood: | n/a | n/a |
41 | CTCF | chr1:154077040-154077190 | GM12873 | blood: | n/a | n/a |
42 | CTCF | chr1:154077019-154077178 | GM12878 | blood: | n/a | n/a |
43 | CTCF | chr1:154077040-154077190 | WERI-Rb-1 | eye: | n/a | n/a |
44 | CTCF | chr1:154077311-154077421 | GM12878 | blood: | n/a | n/a |
45 | CTCF | chr1:154076921-154077289 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | CTCF | chr1:154077020-154077170 | HBMEC | blood vessel: | n/a | n/a |
47 | CTCF | chr1:154077012-154077186 | HepG2 | liver: | n/a | n/a |
48 | CTCF | chr1:154077289-154077438 | GM12891 | blood: | n/a | n/a |
49 | CTCF | chr1:154077297-154077439 | K562 | blood: | n/a | n/a |
50 | CTCF | chr1:154076960-154077110 | SK-N-SH_RA | brain: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:154067602..154069364-chr1:154070769..154072717,2 | K562 | blood: | |
2 | chr1:154067602..154069364-chr1:154070769..154072717,2 | K562 | blood: | |
3 | chr1:154070276..154072411-chr1:154073394..154075388,2 | K562 | blood: | |
4 | chr1:154070276..154072411-chr1:154073394..154075388,2 | K562 | blood: | |
5 | chr1:154068921..154073059-chr1:154073326..154076408,3 | MCF-7 | breast: | |
6 | chr1:154068921..154073059-chr1:154073326..154076408,3 | MCF-7 | breast: | |
7 | chr1:154054884..154056832-chr1:154065709..154068314,2 | MCF-7 | breast: |
No data |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-5698 | chr1:154077038-154077059 | MIMAT0022491 |
No data |
Variant related genes | Relation type |
---|---|
MIR5698 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373248310 | chr1:154067475-154067476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201264601 | chr1:154067481-154067482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568372775 | chr1:154067522-154067523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528494343 | chr1:154067535-154067536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs180784616 | chr1:154067577-154067578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554544199 | chr1:154067579-154067580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566483022 | chr1:154067590-154067591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1416844 | chr1:154067617-154067618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368926918 | chr1:154067655-154067656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538555244 | chr1:154067706-154067707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533866227 | chr1:154067726-154067727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558343293 | chr1:154067728-154067729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77106666 | chr1:154067781-154067782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544382935 | chr1:154067782-154067783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556501879 | chr1:154067791-154067792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185650707 | chr1:154069428-154069429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552199530 | chr1:154069466-154069467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371383477 | chr1:154069484-154069485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537924910 | chr1:154069492-154069493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550028674 | chr1:154069503-154069504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535777361 | chr1:154069549-154069550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12403140 | chr1:154069561-154069562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535259716 | chr1:154069610-154069611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191148415 | chr1:154069667-154069668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572197564 | chr1:154069687-154069688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565760990 | chr1:154069806-154069807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182467458 | chr1:154069816-154069817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73010796 | chr1:154069928-154069929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576160214 | chr1:154069995-154069996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543533991 | chr1:154070023-154070024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561815214 | chr1:154070030-154070031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574188320 | chr1:154070083-154070084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541221848 | chr1:154070097-154070098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560043519 | chr1:154070098-154070099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374416906 | chr1:154070169-154070170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs143664918 | chr1:154070191-154070192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572900879 | chr1:154070242-154070243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552236378 | chr1:154070326-154070327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564049844 | chr1:154070327-154070328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189116276 | chr1:154070353-154070354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549916931 | chr1:154070366-154070367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs138328348 | chr1:154070381-154070382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535639593 | chr1:154070426-154070427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547270110 | chr1:154070433-154070434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566003073 | chr1:154070517-154070518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539329909 | chr1:154070546-154070547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191826337 | chr1:154070673-154070674 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs58300038 | chr1:154070707-154070708 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs537009821 | chr1:154070768-154070769 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555446253 | chr1:154070769-154070770 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 17440070 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:154067000-154067600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
2 | chr1:154067000-154067800 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr1:154069400-154071000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr1:154070400-154070800 | Enhancers | Psoas Muscle | Psoas |
5 | chr1:154070400-154071200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr1:154070600-154071200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
7 | chr1:154071000-154071400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr1:154071400-154076800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr1:154076200-154076400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr1:154076400-154076800 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr1:154076600-154077600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr1:154076800-154077400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr1:154076800-154077400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr1:154076800-154077600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr1:154076800-154077600 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr1:154076800-154077600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr1:154077000-154077400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
18 | chr1:154077000-154077600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr1:154077200-154077600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
20 | chr1:154077200-154077600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
21 | chr1:154077200-154077600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
22 | chr1:154077200-154077800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
23 | chr1:154078600-154079200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
24 | chr1:154079200-154079400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
25 | chr1:154086600-154087400 | Enhancers | Primary T cells fromperipheralblood | blood |
26 | chr1:154086800-154087600 | Enhancers | Primary T cells from cord blood | blood |
27 | chr1:154086800-154087600 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
28 | chr1:154086800-154088200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
29 | chr1:154086800-154088400 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |